What's behind Astera Labs's latest stock pullback?

Traders Union
All News
Stocks
Astera Labs slides 8.76% today

Highlights

Astera Labs reported record Q2 2026 revenue of $392.4 million, up 104% year over year on strong AI connectivity demand.
Over half of quarterly revenue stemmed from PCIe 6.0 solutions, and Q3 2026 guidance was raised to $540 to $560 million.
Despite long-term bullish structure, Astera Labs stock faces medium-term resistance with short-term volatility and a projected five-day range of $282.56 to $377.4.

AI demand drives record results amid lingering downside pressure

Astera Labs reported record second-quarter 2026 revenue of $392.4 million, marking a 104% year-over-year increase. The rise was attributed to accelerated demand for AI infrastructure connectivity and strong uptake of the company's Scorpio X switches, with over half of the quarter's revenue coming from PCIe 6.0 solutions. Guidance for Q3 2026 was issued in the range of $540–560 million, accompanied by new design wins and continued expansion of the connectivity solutions portfolio, though price action has remained under broader selling pressure.

Anton Kharitonov, expert at Traders Union, sees Astera Labs under heavy selling pressure despite strong revenue growth and guidance. He notes that rejection at the 50-day moving average and intraday volatility highlight persistent risk from sellers. Kharitonov views mixed momentum signals and overbought indicators as warning signs for buyers. The expert cautions that a break below $329.29 could expose the price to further losses towards $282.56. "Any positive headline is currently outweighed by profit taking and technical resistance, so I advise caution until the selling pressure eases."

Viktoras Karapetjanc, expert at Traders Union, views Astera Labs’ fundamentals as robust following record-breaking revenue and upbeat guidance driven by AI infrastructure demand. Karapetjanc highlights successful expansion in the PCIe 6.0 space and new design wins as signals of deepening market penetration. He considers the technical backdrop bullish overall, with the 200-day average and the long-term trend still intact. "This setup points to a constructive outlook, and as growth drivers persist, further upside toward $377.40 remains probable in the coming sessions."

Sholanke Dele, market strategist, believes short-term sentiment is fragile amid increased volatility and heavy post-earnings selling. Dele points to macro headwinds, seeing broader market weakness amplifying intraday swings in Astera Labs. He finds that buyer enthusiasm has failed to overcome prevailing resistance. "Unless risk appetite improves markedly, I expect this volatility band to cap any sharp rebounds for now."

Bullish structure constrained by mid-term resistance and mixed momentum

Astera Labs is trading above both its 20-day and 200-day moving averages ($329.29 and $209.38) but remains below the 50-day level at $357.15, illustrating a long-term bullish trend constrained by medium-term resistance from sellers. Today’s high at $351.94 defines the near-term ceiling, with immediate support at the 20-day moving average ($329.29). The Ichimoku Kijun ($372.05) acts as a distant resistance, supporting the underlying uptrend. Momentum signals are mixed: MACD and ADX reflect ongoing selling pressure and weakening trend strength, while the RSI suggests a potential buy at 55.41. However, Stochastic RSI and Bull/Bear Power flag overbought conditions amid dominant intraday buyer action, and both the Commodity Channel Index and Awesome Oscillator show neutral readings.

Earlier, analysts noted that while Astera Labs demonstrated strong growth prospects and institutional interest, its shares faced persistent selling pressure despite a bullish long-term structure. The latest results reinforce the ongoing tug-of-war between robust business momentum and technical resistance, making a sustained move above the 50-day moving average a critical level for traders monitoring the next directional shift.

Source of Data: ALAB Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.